BiotechTube
Home/BIT Pharma/Dr. Peter Hölig
DP

Dr. Peter Hölig

Technology Development Expert

BIT Pharma

Therapeutic Areas

Central Nervous System

BIT Pharma Pipeline

DrugIndicationPhase
NicaPlant®Undisclosed CNS condition(s) (High unmet medical need, life-threatening)Pre-clinical

Leadership Team at BIT Pharma

PD
Prof. Dr. Jörg Breitenbach
Chief Executive Officer
DT
Dr. Tiziana Adage
Chief Scientific Officer
DD
Dr. Doris Maier
Chief Financial Officer
PD
Prof. Dr. Peter Vajkoczy
Clinical Advisor
View full BIT Pharma profile